135237-01-3 Usage
Uses
Used in Organic Synthesis:
2-(1H-Pyrazol-3-yl)acetonitrile is used as a building block in organic synthesis for the creation of various heterocyclic compounds. Its unique structure allows for the formation of diverse chemical entities, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(1H-Pyrazol-3-yl)acetonitrile serves as a key intermediate for the development of new drugs. Its ability to form a wide range of heterocyclic compounds contributes to the discovery of potential therapeutic agents with novel mechanisms of action.
Used in Agrochemical Production:
2-(1H-Pyrazol-3-yl)acetonitrile is employed as a precursor in the synthesis of agrochemicals. Its incorporation into these compounds can lead to the development of new pesticides or herbicides with improved efficacy and selectivity.
Used in Dye Manufacturing:
In the dye industry, 2-(1H-Pyrazol-3-yl)acetonitrile is utilized in the production of various dyes. Its chemical properties enable the creation of dyes with unique color characteristics and stability, catering to specific applications in textiles, printing, and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 135237-01-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,2,3 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 135237-01:
(8*1)+(7*3)+(6*5)+(5*2)+(4*3)+(3*7)+(2*0)+(1*1)=103
103 % 10 = 3
So 135237-01-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N3/c6-3-1-5-2-4-7-8-5/h2,4H,1H2,(H,7,8)
135237-01-3Relevant academic research and scientific papers
INDOLE AHR INHIBITORS AND USES THEREOF
-
Paragraph 00894-00895, (2018/11/22)
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
-
Paragraph 0175, (2014/05/24)
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
